Product
cetuximab+immunochemotharpy
1 clinical trial
1 indication
Indication
Head and Neck Squamous CarcinomaClinical trial
Neoadjuvant Stereotactic Body Radiotherapy（SBRT）Combined With Immunotherapy for Locally Advanced Head and Neck Squamous Cell CarcinomaStatus: Recruiting, Estimated PCD: 2026-12-31